Showing results (591-600 of 689) with videos related to

Sort By:
Pageof 69
International Journal of Environmental Research and Public Health|August 26, 2022
Historical Changes in Weight Classes and the Influence of NAFLD Prevalence: A Population Analysis of 34,486 IndividualsBenjamin Kai Yi Nah, Cheng Han Ng, Kai En Chan, et al.
Alimentary Pharmacology & Therapeutics|September 11, 2023
The silent burden of non-alcoholic fatty liver disease in the elderly: A global burden of disease analysisPojsakorn Danpanichkul, Cheng Han Ng, Mark D Muthiah, et al.
Alimentary Pharmacology & Therapeutics|March 14, 2022
Meta-analysis: analysis of mechanistic pathways in the treatment of non-alcoholic steatohepatitis. Evidence from a Bayesian network meta-analysisCheng Han Ng, Mark D Muthiah, Jieling Xiao, et al.
Diabetes Care|May 28, 2025
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in People With Diabetes: The Need for Screening and Early Intervention. A Consensus Report of the American Diabetes AssociationKenneth Cusi, Manal F Abdelmalek, Caroline M Apovian, et al.
JHEP Reports : Innovation in Hepatology|May 5, 2025
Liver fibrosis progression analyzed with AI predicts renal declineDan-Qin Sun, Jia-Qi Shen, Xiao-Fei Tong, et al.
Radiology|October 10, 2023
Repeatability of MRI Biomarkers in Nonalcoholic Fatty Liver Disease: The NIMBLE ConsortiumKathryn J Fowler, Sudhakar K Venkatesh, Nancy Obuchowski, et al.
Annals of Hepatology|October 1, 2022
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysisMark Muthiah, Cheng Han Ng, Kai En Chan, et al.
Hepatology (Baltimore, Md.)|October 18, 2021
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitisArun J Sanyal, Quentin M Anstee, Michael Trauner, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2023
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b StudyManal F Abdelmalek, Arun J Sanyal, Atsushi Nakajima, et al.
Obesity (Silver Spring, Md.)|June 23, 2025
Tirzepatide for reduction of morbidity and mortality in adults with obesity: rationale and design of the SURMOUNT-MMO trialCarolyn S P Lam, Angel Rodriguez, Ali Aminian, et al.
Pageof 69